SpliceBioGene therapySpliceBio lauches Phase I/II study on du...Spanish SpliceBio has dosed the first patient with SB-007, the first dual AAV gene therapy in clinical development for Stargardt disease more ➔
FSA UKCell-based meatRegulatory sandbox will speed up safety...The UK Food Standards Agency (FSA) has selected eight companies to participate in a two-year regulatory programme set to speed up market approval and safety assessment of cell-cultivated products. more ➔
asobe stock photos - catalin ObesityRoche inks US$1.65bn obesity deal with Z...Roche is extending its obesity pipeline signing a US$5.3bn biobucks deal with Zealand Pharma A/S, who will co-develop and co-commercialise a monotherapy of its long-acting amylin analogue petrelintide … more ➔
Adobe stock - maurice norbert ObesityNovo Nordisk’s obesity drug CagriS...Novo Nordisk A/S’ combined GLP1-, amylin- and calcitonin receptor agonist CagriSema has failed to meet the expected 25% weight loss within 68 weeks in the second of four pivotal Phase III trials. Shares … more ➔
Roche AGSLAS/AutomationRoche unveils completely new sequencing...Roche researchers have introduced a greatly improved long-read nanopore sequencing method that has the potential to erase the sequencing-by-synthesis approach of market leader Illumina. more ➔
Hummingbird BioscienceFinancingADC maker Callio Therapeutics secures US...Investment company Frazier Life Sciences has launched the virtual ADC company Callio Therapeutics Inc by licencing Hummingbird Bioscience’s TopDDRive dual payload ADC technology and co-leading a US$187m … more ➔
Audiovisual Library of the European CommissionEU CommissionEU Commission presents Clean Industrial...The European Commission has presented its long-awaited Clean Industrial Deal, which aims at replacing its Green Deal in times of geopolitical tensions, slow economic growth and technological competition … more ➔
Fuse VectorsPre-seed FinancingGene therapy manufacturing: Fuse Vectors...Fuse Vectors has secured US$5.2m in pre-seed financing to revolutionise gene therapy manufacturing with its cell-free viral vector technology. The Danish company is aiming to make treatments more accessible … more ➔
Ryvu Therapeutics zooCancer therapeuticsRyvu Therapeutics extends cashflow to co...Krakow-based oncology specialist Ryvu Therapeutics zoo today announced a strategic reorganisation that will extend Ryvu’s cash runway to H2/2026 to focus on accelerating three ongoing RVU120 clinical … more ➔
CSUElectionsNew German Chancellor wants a strong Eur...With a 7.7% lead, the incoming Christian Democrat Chancellor Friedrich Merz has put the radical right-wing AfD in its place. Before forming a government in Germany, Merz emphasised that Germany wants … more ➔
SpliceBio
FSA UK
asobe stock photos - catalin 
Adobe stock - maurice norbert 
Roche AG
Hummingbird Bioscience
Audiovisual Library of the European Commission
Fuse Vectors
Ryvu Therapeutics zoo
CSU